Christopher Paul German - Mar 20, 2024 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Corporate Controller & CAO
Signature
/s/ Christopher Paul German
Stock symbol
RYTM
Transactions as of
Mar 20, 2024
Transactions value $
-$15,368
Form type
4
Date filed
4/3/2024, 08:00 PM
Previous filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +1.16K 1.16K Mar 20, 2024 Direct F1
transaction RYTM Common Stock Sale -$15.4K -368 -31.64% $41.76 795 Apr 2, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -1.16K -25.01% $0.00 3.49K Mar 20, 2024 Common Stock 1.16K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The sale reported in this Form 4 was effected pursuant to non-Rule 10b5-1 trading arrangement, as defined in Item 408(a) of Regulation S-K, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $41.55 to $41.76. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The restricted stock units have vested or will vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 20, 2026 and March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.

Remarks:

Exhibit 24 - Power of Attorney